|

Signifor Clinical Trials

1 actively recruiting trial

Also known as: ATC-Code: H01CB05

Pipeline

Phase 2: 1

Top Sponsors

  • University Hospital Heidelberg1

Indications

  • Desmoplastic Small Round Cell Tumor1
  • Synovial Sarcoma1
  • Cancer1

Other1 trial

Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.